Old Web
English
Sign In
Acemap
>
authorDetail
>
James Liang
James Liang
Middlemore Hospital
Medicine
Immunology
Diabetes mellitus
Anemia
Cadherin
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 2, Open-Label, Ascending Dose Study of Ker-050 for the Treatment of Anemia in Patients with Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
2021
Blood
David M. Ross
Alejandro Arbelaez
Lynette C.Y. Chee
Chun Yew Fong
Devendra K. Hiwase
George Kannourakis
John Kwan
James Liang
Anish Puliyayil
Hannah Rose
Shuhying Tan
Tse-Chieh Teh
David Westerman
Joel Wight
Chris Rovaldi
Elissa Furutani
Adrienne Gaggi
Ying Jiang
Jenn Lachey
Harveen Dhillon Natarajan
Claudia Ordonez
Show All
Source
Cite
Save
Citations (0)
High dose carfilzomib proteasome inhibition induces anemia by oxidative hemolysis: A case series of 8 patients from a single centre
2019
American Journal of Hematology
Rajeev Rajagopal
Rory Bennett
James Liang
Gordon Royle
Show All
Source
Cite
Save
Citations (1)
Pure erythroid leukemia: The value of E-cadherin in making the diagnosis
2019
American Journal of Hematology
Imogen Caldwell
Anna Ruskova
Gordon Royle
James Liang
Barbara J. Bain
Show All
Source
Cite
Save
Citations (1)
1